13.57 USD
▼+0.42-4.03%
盘后 14.42 +1.98%
2026-08-03
市值
$121.69M
市盈率
—
EPS
-13.36
股息率
—
52 周区间
6.27 – 27.40
成交量
18.75K
Beta
-0.22
目标价
39.35
52W 低 6.2752W 高 27.40
价格走势
公司简介
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company’s proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein biology, physics, and supercomputing. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's disease; PMN267 for the treatment of amyotrophic lateral sclerosis; and PMN442, a mAb targeting t...